- Home
- KURA vs HOUS Comparison
KURA vs HOUS Comparison
Compare KURA & HOUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- HOUS
- Stock Information
- Founded
- KURA 2014
- HOUS 2006
- Country
- KURA United States
- HOUS United States
- Employees
- KURA N/A
- HOUS N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- HOUS Real Estate
- Sector
- KURA Health Care
- HOUS Finance
- Exchange
- KURA Nasdaq
- HOUS Nasdaq
- Market Cap
- KURA 713.5M
- HOUS 799.9M
- IPO Year
- KURA N/A
- HOUS 2006
- Fundamental
- Price
- KURA $10.14
- HOUS $10.02
- Analyst Decision
- KURA Buy
- HOUS Hold
- Analyst Count
- KURA 14
- HOUS 3
- Target Price
- KURA $24.45
- HOUS $8.50
- AVG Volume (30 Days)
- KURA 1.8M
- HOUS 4.7M
- Earning Date
- KURA 11-06-2025
- HOUS 11-06-2025
- Dividend Yield
- KURA N/A
- HOUS N/A
- EPS Growth
- KURA N/A
- HOUS N/A
- EPS
- KURA N/A
- HOUS N/A
- Revenue
- KURA $83,279,000.00
- HOUS $5,783,000,000.00
- Revenue This Year
- KURA $68.63
- HOUS $7.03
- Revenue Next Year
- KURA $141.59
- HOUS $6.25
- P/E Ratio
- KURA N/A
- HOUS N/A
- Revenue Growth
- KURA N/A
- HOUS 2.74
- 52 Week Low
- KURA $5.41
- HOUS $2.71
- 52 Week High
- KURA $19.73
- HOUS $12.03
- Technical
- Relative Strength Index (RSI)
- KURA 69.23
- HOUS 72.43
- Support Level
- KURA $9.48
- HOUS $9.72
- Resistance Level
- KURA $9.96
- HOUS $10.73
- Average True Range (ATR)
- KURA 0.41
- HOUS 0.53
- MACD
- KURA 0.06
- HOUS 0.15
- Stochastic Oscillator
- KURA 81.78
- HOUS 59.59
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About HOUS Anywhere Real Estate Inc.
Anywhere Real Estate Inc operates in residential real estate, focusing on brokerage, relocation, title, settlement businesses, and mortgage and title insurance ventures. It supports approximately 1 million home sale sides annually. Brands include Better Homes and Gardens, CENTURY 21, Coldwell Banker, Corcoran, ERA, and Sotheby's International Realty. Revenue comes mainly from existing home transactions. Operations are segmented into Anywhere Brands (franchises), Anywhere Advisors (owned brokerage), and Anywhere Integrated Services (title and settlement).